Throat Cancer Treatment Market – Status and Development, Average Product Price and Market Shares of Key Players
The increasing incidence rate of pharyngeal cancer and rising aging population is likely to aid in the market growth of throat cancer treatment.
HYDERABAD, TELANGANA, INDIA, January 11, 2023 /EINPresswire.com/ -- Throat Cancer Treatment Market size is forecast to reach 3.89Bn by 2025, growing at a CAGR of 7.87% during the forecast period 2020-2025. Throat cancer refers to cancerous tumours that develop in the throat (pharynx), voice box (larynx) or tonsils. The increasing incidence of throat cancer and increasing awareness regarding throat cancer are the major factors driving the growth of the market. The increasing smoking population is set to further enhance the overall market demand for throat cancer treatment during the forecast period 2020-2025.Click here to browse the complete report summary:
https://www.industryarc.com/Report/16874/throat-cancer-treatment-market.html
Key Takeaways
1. North America dominates the Throat Cancer Treatment Market owing to the increasing smoke pollution and increasing alcohol consumption. The Throat Cancer Treatment Market scope for different regions will be provided in the final report.
2. The increasing incidence rate of pharyngeal cancer and the rising ageing population is likely to aid in the market growth of throat cancer treatment.
3. Detailed analysis of the Strength, Weaknesses and Opportunities of the prominent players operating in the market will be provided in the Throat Cancer Treatment Market report.
4. Side effects of chemotherapy drugs and lack of proper diagnosis of the disease is set to create hurdles for the Throat Cancer Treatment Market
Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=16874
Segment Analysis
1. The Laryngeal Cancer segment held the largest share of the Throat Cancer Treatment Market and is estimated to grow at a CAGR of 6.34% during the forecast period 2020-2025. Laryngeal cancers are mostly squamous cell carcinomas, reflecting their origin in the skin of the larynx. Cancer can develop in any part of the larynx, but the cure rate is affected by the location of the tumour. For the purposes of staging, the larynx is divided into three anatomical regions- the glottis (true vocal cords, anterior and posterior commissures), the supraglottis (epiglottis, arytenoids and aryepiglottic folds, and false cords) and the subglottis. Laryngeal cancer is set to spread by direct extension to adjacent structures, by metastasis to regional cervical lymph nodes or more distantly, through the bloodstream. The most important risk factor for laryngeal cancer is smoking. Laryngeal Cancer is set to be the fastest-growing segment during the forecast period 2020-2025.
2. The chemotherapy segment held the largest share of the Throat Cancer Treatment Market in 2019 and is estimated to grow at a CAGR of 5.19% during the forecast period 2020-2025. Chemotherapy uses drugs to kill cancer cells. Chemotherapy is often used along with radiation therapy in treating throat cancers. Certain chemotherapy drugs make cancer cells more sensitive to radiation therapy. But combining chemotherapy and radiation therapy increases the side effects of both treatments. Radiation therapy uses high-energy beams from sources such as X-rays and protons to deliver radiation to cancer cells, causing them to die. Radiation therapy can come from a large machine outside your body (external beam radiation) or radiation therapy can come from small radioactive seeds and wires that can be placed inside your body, near your cancer (brachytherapy). Chemotherapy is set to be the fastest-growing segment during the forecast period 2020-2025 boosting the growth of the Throat Cancer Treatment Market.
3. North America dominates the throat cancer treatment market with a share of more than 39%, followed by Europe owing to the increasing smoke pollution and increasing alcohol consumption. A rising ageing population and increasing prevalence of both pharyngeal cancer and laryngeal cancer are boosting the growth of the throat cancer treatment market. However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the increase in tobacco and alcohol consumption in this region.
Competitive Landscape:
The top 5 players in the Throat Cancer Treatment Industry are -
1. Bristol Myers Squibb Co
2. Hospira Inc
3. Baxter International Inc
4. Teva Pharmaceutical Industries Ltd
5. Mylan Pharmaceuticals Inc
Click on the following link to buy the Throat Cancer Treatment Market Report:
https://www.industryarc.com/reports/request-quote?id=16874
Why Choose IndustryARC?
IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.
Related Reports:
A. Head & Neck Cancer Drugs Market
https://www.industryarc.com/Research/Head-Neck-Cancer-Drugs-Market-Research-506918
B. Cancer Biomarkers Market
https://www.industryarc.com/Report/15738/cancer-biomarkers-market.html
Contact Us:
Mr Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062
Venkat Reddy
IndustryARC
+1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
